Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma

scientific article

Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1027922625
P356DOI10.1007/S00280-016-3202-8
P698PubMed publication ID27913882

P2093author name stringSeung Kew Yoon
Jong Young Choi
Sung Won Lee
Jeong Won Jang
Hae Lim Lee
Si Hyun Bae
Nam Ik Han
P2860cites workTransarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and futureQ26771776
Risk of tumor cell seeding through biopsy and aspiration cytologyQ26827557
Biology of hepatocellular carcinomaQ28266656
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalQ29616865
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialQ29617955
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaQ29617957
Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysisQ33778970
Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment?Q34065128
Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.Q34552875
Predictors of mortality in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationQ35178251
Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients.Q35877902
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE StudyQ36404761
Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular CarcinomaQ36423170
Modified RECIST (mRECIST) assessment for hepatocellular carcinomaQ37696396
In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?Q38984450
Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinomaQ41235807
DC Bead Transarterial Chemoembolization Is Effective in Hepatocellular Carcinoma Refractory to Conventional Transarteral Chemoembolization: A Pilot StudyQ42153654
A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan CriteriaQ43484980
Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.Q44453052
Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinomaQ44835494
Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantationQ46082144
Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinomaQ48351437
Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study.Q50770174
Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.Q51873576
P433issue1
P304page(s)81-88
P577publication date2016-12-02
P1433published inCancer Chemotherapy and PharmacologyQ326137
P1476titleEarly treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma
P478volume79

Reverse relations

cites work (P2860)
Q33442349A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma.
Q93090362Database analysis of patients with hepatocellular carcinoma and treatment flow in early and advanced stages

Search more.